Search results
Results From The WOW.Com Content Network
Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. [7] In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea. [8] It is taken by mouth. [7] It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet ...
In December 2020, the U.S. Food and Drug Administration (FDA) approved labeling changes stating that Januvia (sitagliptin), Janumet (sitagliptin and metformin hydrochloride), and Janumet XR (sitagliptin and metformin hydrochloride extended-release) are not proven to improve glycemic (blood sugar) control in children aged 10 to 17 with type 2 ...
Dipeptidyl peptidase-4 inhibitor. Inhibitors of dipeptidyl peptidase 4 ( DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2 . The first agent of the class – sitagliptin – was approved by the FDA in 2006.
Januvia, Merck : $113 per month. ... The lawsuit by PhRMA is awaiting a change in location after a Texas judge dismissed the case saying his court lacks jurisdiction. No new location has been ...
The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the "non-drowsy" claim from its ...
Of 10,500 complaints filed by black people between 2011 and 2015, just 166 — or 1.6 percent — were sustained or led to discipline after an internal investigation. Overall, the authority sustained just 2.6 percent of all 29,000 complaints. Nationally, between 6 and 20 percent of citizen-initiated complaints are sustained, said Lou Reiter, a ...
Januvia (sitagliptin) is a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. In 2013, Januvia was the second largest selling diabetes drug worldwide. [11] Januvia is commonly paired with the generic anti-diabetes drug metformin. It has been popular due in part because unlike many other diabetes drugs, it causes little or ...
A Texas judge last month dismissed a lawsuit brought by the pharmaceutical industry’s main lobbying group and two other organizations, while an Ohio judge last year denied an attempt by the US ...